WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR TherapeuticTM, today announced that:
J. Donald deBethizy, Ph.D., Targacept’s President and Chief Financial Officer, is scheduled to present at the BIO CEO and Investor Conference at the Waldorf=Astoria Hotel in New York City on Tuesday, February 14, 2012 at 1:30 p.m. Eastern Time
J. Donald deBethizy, Ph.D., Targacept’s President and Chief Financial Officer, is scheduled to present at the BIO CEO and Investor Conference at the Waldorf=Astoria Hotel in New York City on Tuesday, February 14, 2012 at 1:30 p.m. Eastern Time
